|
|
|
11.03.26 - 14:09
|
Clearmind Medicine Advances Recruitment for CMND-100 Trial′s Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results (GlobeNewswire EN)
|
|
|
Vancouver, Canada, March 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the continuation of participant enrollment for the third cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD)....
|
|
|
11.03.26 - 13:18
|
Director/PDMR Shareholding (Cision)
|
|
|
Vesuvius plc
11 March 2026
Notification of Transactions of Persons Discharging Managerial Responsibilities
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
+--------------+----------------------------+---------+---------+-+-+
|1 |Details of the person |
| |discharging managerial |
| |responsibilities / person |
| |closely associated...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.03.26 - 08:06
|
Final Results (Cision)
|
|
|
Bodycote plc – 2025 Full Year Results
Good strategic progress in mixed markets
Group summary Adjusted1 Statutory
Full year Full year Full Full year
year
2025 2024 Change 2025 2024 Change
Revenue £727.1m £757.1m -4.0% £727.1m £757.1m -4.0%
Operating profit £114.3m £129.0m -11.4% £83.6m £37.9m +121%
Operating margin 15.7% 17.0% -130 11.5% 5.0% +650 bps...
|
|
|
|
|
10.03.26 - 16:12
|
More great news for Rolls-Royce shares! (Fool)
|
|
|
Rolls-Royce shares got a boost this week after some intriguing developments in the process of creating Europe's new fighter aircraft.
The post More great news for Rolls-Royce shares! appeared first on The Motley Fool UK....
|
|
|
|
|
|
|
|
|
|
|
10.03.26 - 12:06
|
Dacke Industri strengthens its position in Europe through the acquisition of Rotork Midland Ltd (to be renamed Midland Flow Ltd) in the UK (Cision)
|
|
|
In line with our strategy to strengthen our presence in key markets, Dacke Industri today announces the acquisitions of the UK-based Rotork Midland Ltd, (to be renamed Midland Flow Ltd) and the Italian Rotork Instruments S.r.l. (to be renamed M&M Instruments S.r.l.) as part of the divestment process from Rotork Plc. These acquisitions demonstrate our commitment to growth, enhance our market position, and open new opportunities for collaboration and customer value in both the UK and Italy.
On March 5th, 2026, we acquired 100% of the shares in Rotork Midland Ltd, (to be renamed Midland Flow...
|
|
|
10.03.26 - 12:06
|
Dacke Industri expands its European footprint with the acquisition of Rotork Instruments S.r.l. (to be renamed M&M Instruments S.r.l.) in Italy (Cision)
|
|
|
In line with our strategy to strengthen our presence in key markets, Dacke Industri today announces the acquisitions of the UK-based Rotork Midland Ltd, (to be renamed Midland Flow Ltd) and the Italian Rotork Instruments S.r.l. (to be renamed M&M Instruments S.r.l.) as part of the divestment process from Rotork Plc. These acquisitions demonstrate our commitment to growth, enhance our market position, and open new opportunities for collaboration and customer value in both the UK and Italy.
On March 5th, 2026, we acquired 100% of the shares in Rotork Instruments S.r.l. (to be renamed M&M...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
